GTx, Inc. (GTXI) – FDA
-
GTx, Inc. (GTXI) ASTRID Trial of Enobosarm in Women with Stress Urinary Incontinence Doesn't Achieve Primary Endpoint
-
GTx, Inc. (GTXI) Reports Early Completion of Patient Enrollment in the ASTRID Trial, a Phase 2 Clinical Trial of Enobosarm
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GTXI Stock Lookup